We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Tosses Teva’s Latest Citizen Petition Seeking Greater Scrutiny of Generic Copaxone
FDA Tosses Teva’s Latest Citizen Petition Seeking Greater Scrutiny of Generic Copaxone
The FDA has rejected Teva’s seventh citizen petition calling for the agency to boost its scrutiny of any ANDA seeking to make a generic version of the Israeli firm’s blockbuster multiple sclerosis drug Copaxone.